News Headlines Article

Two UC Davis efforts get state regenerative-medicine grants
Sacramento Business Journal

The California Institute for Regenerative Medicine has approved more than $3.2 million in funding for two research efforts at the UC Davis Health System and School of Medicine in Sacramento.

The larger award, $2.3 million, went to a team using stem cells to kill cancer cells in patients with aggressive malignancies.

Another award of $883,000 went to an effort to treat the fatal childhood condition Tay-Sachs disease.

Dr. William Murphy, a professor of dermatology and internal medicine and a specialist in cancer immunology, is leading the team that is researching the use of targeting malignant cells in aggressive cancers, such as breast cancer, pancreatic cancer and sarcomas.